Clinical Trial

Sequential Combined Versus Single-Strategy Adrenal Venous Sampling for Primary Aldosteronism(SCOPE)

Recruiting
View on ClinicalTrials.gov →
Summary
This study is a prospective, multicenter, randomized clinical trial aimed to compare the impact of three AVS diagnostic strategies on the clinical outcomes of patients with primary aldosteronism. The strategies include sequential combined AVS (non-ACTH-stimulated followed by ACTH-stimulated AVS), non- ACTH-stimulated AVS alone, and ACTH-stimulated AVS alone. The findings of this study will provide critical evidence for the clinical practice standards of AVS.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-12-10.
Status change: Not Yet Recruiting → Recruiting 2025-12-22
Trial Details
NCT Number NCT07298954
Lead Sponsor Shumin Yang
Collaborators: First Affiliated Hospital of Kunming Medical University, The First Affiliated Hospital of Nanchang University, The People's Hospital of Chuxiong Yi Autonomous Prefecture
Conditions Primary Aldosteronism
Enrollment 456 participants
Start Date 2025-12-25
Primary Completion 2027-12-31 (estimated)
Study Completion 2028-12-31 (estimated)
Updated on ClinicalTrials.gov 2025-12-24